Mofegiline hydrochloride (MDL-72,974) is a selective, irreversible inhibitor of monoamine oxidase B (MAO-B) and amine oxidase, copper containing 3 (AOC3) or vascular adhesion protein 1 (VAP-1), also known as semicarbazide-sensitive amine oxidase (SSAO). Mofegiline hydrochloride demonstrates a time dependent irreversible inhibition of SSAO. In rat studies, Mofegiline hydrochloride showed preferential inhibition of brain MAO-B with ED50 values of 8 and 0.18 mg/kg p.o. for the A and B forms, respectively. In anaesthetized rats, Mofegiline hydrochloride did not significantly potentiate tyramine effects on the cardiovascular system. Mofegiline hydrochloride was studied and extensively researched as a potential treatment of Parkinson′s disease and Alzheimer′s disease, but was never marketed.
Specifications and Purity: ≥97%
Molecular Formula: C11H13F2N•HCl
Molecular Weight: 233.69
PubChem CID: 6446650
Isomeric SMILES: C1=CC(=CC=C1CC/C(=C/F)/CN)F.Cl
Related Documents: https://aladdin-for-icloud-store.oss-cn-hangzhou.aliyuncs.com/aladdinsci/pdp/sds/1/M339862-SCI_c8e1819ccd6fb7718e9200b15dd87c06.pdf
- UPC:
- 51101510
- Condition:
- New
- HazmatClass:
- No
- WeightUOM:
- LB
- MPN:
- M339862-100mg
- CAS:
- 120635-25-8
- Product Size:
- 100mg
- Hazard Statement Codes:
- H335:H319:H302
- Precautionary Statement Codes:
- P280:P271:P270:P264:P261
akash.verma@cenmed.com
(732) 447-1115





